Related Experiment Video

Updated: Jun 4, 2026

Sex Stratified Neuronal Cultures to Study Ischemic Cell Death Pathways
10:44

Sex Stratified Neuronal Cultures to Study Ischemic Cell Death Pathways

Published on: December 9, 2013

Pharmacological approach to patients with non-ST segment elevation myocardial infarction: does sex make a difference?

Agnieszka Janion-Sadowska1, Janusz Sielski, Marek Gierlotka

  • 1Acute Cardiac Care Unit, Świętokrzyskie Cardiology Center, Kielce, Poland. ajanion@o2.pl

Polskie Archiwum Medycyny Wewnetrznej
|February 25, 2011
PubMed

Insights

This study found no significant pharmacotherapy differences between men and women with non-ST-segment elevation myocardial infarction. However, internal medicine wards prescribed fewer beta-blockers, statins, and ACE inhibitors compared to cardiology wards.

Area of Science:

  • Cardiology
  • Pharmacotherapy
  • Health Outcomes

Background:

  • Recent studies suggest higher mortality in women with acute coronary syndromes may stem from suboptimal medication use.
  • Key medications include antiplatelet agents, statins, beta-blockers, and ACE inhibitors.

Purpose of the Study:

  • To compare pharmacotherapy in men and women with non-ST-segment elevation myocardial infarction (NSTEMI).
  • To assess treatment variations between cardiology and general internal medicine wards.

Main Methods:

  • A registry-based study of 682 NSTEMI patients (43.4% women) in Poland.
  • Comparison of in-hospital and discharge pharmacotherapy between genders and ward types.

Main Results:

  • No significant pharmacotherapy differences were observed between male and female patients within the same ward type.
  • Cardiology wards administered ticlopidine, clopidogrel, and unfractionated heparin more frequently.
  • Internal medicine wards showed significantly lower prescription rates for aspirin, clopidogrel, ACE inhibitors, statins, and beta-blockers at discharge.

Conclusions:

  • No gender-based disparities in pharmacotherapy were found within comparable facilities.
  • Internal medicine wards were associated with less frequent prescription of beta-blockers, statins, and ACE inhibitors at discharge.
Abstract

More Related Videos

Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control05:41

Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control

Published on: December 16, 2022

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs14:35

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs

Published on: April 17, 2021

Related Concept Videos

Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Antianginal Drugs: Nitrates and β-Blockers01:16

Antianginal Drugs: Nitrates and β-Blockers

In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates,  such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...
Antianginal Drugs: Calcium Channel Blockers and Ranolazine01:25

Antianginal Drugs: Calcium Channel Blockers and Ranolazine

Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Angina V: Nursing Management01:20

Angina V: Nursing Management

Angina, a symptom of myocardial ischemia, requires a structured nursing management approach to ensure effective care and prevent complications like myocardial infarction. Comprehensive nursing care involves assessing, diagnosing, planning, implementing interventions, and evaluating outcomes, all tailored to the individual patient's needs.Patient AssessmentNursing assessment begins with a detailed subjective evaluation of symptoms, which typically include chest pain or pressure radiating to the...